跳至主要内容
临床试验/NL-OMON43049
NL-OMON43049招募中不适用

Defining the optimal dose for continuous flucloxacillin infusion using pharmacokinetic modelling ;The FLUCON-study - Flucon

Deventer Ziekenhuis0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Part A;In order to be eligible to participate in this study, a subject must meet;all of the following criteria:;- The patient is at least 18 years of age;- The patient has started with intravenous flucloxacillin as indicated by;their physician;At least 10 of the 30 patients are treated with flucloxacillin for a bacteriemia;Part B;In order to be eligible to participate in this study, a subject must meet;all of the following criteria:;- The patient is at least 18 years of age;- The patient has an indication for the treatment of flucloxacillin with;continuous infusion as indicated by their physician

排除标准

  • Part A and B;A potential subject who meets any of the following criteria will be;excluded from participation in this study because of the altered;pharmacokinetics:;- The patient who is admitted to the intensive care unit;- Pregnant women

研究者

相似试验